Business Overcoming process development and biologics manufacturing challenges

1. MaRS | May 15, 2009 Thomas G. Wellner – President & CEO Dr. David N. Bell – VP Drug Development & CSO www.therapurebio.com 2. of all new products The future…

Technology Therapure Bio Contact Presentation Sept 29 08

1. BioContact Presentation | Fall 2008 www.therapurebio.com 2. of all new products The future of medicine 1 3 / 3. $51B $87B $25B $89B 2001 Protein therapeutic market 2005…